• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Precision gene editing could prevent vision loss from Stargardt disease

January 10, 2025
in Medical Research
Reading Time: 3 mins read
A A
0
Precision gene editing could prevent vision loss from Stargardt disease
7
SHARES
15
VIEWS
Share on FacebookShare on Twitter


Precision gene editing could prevent vision loss from Stargardt disease
Among the rare diseases, Stargardt disease is one of the most common affecting the retina. Credit: IOB

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, which often leads to vision loss. Their study shows promising results using a precise technique for gene correction.

Stargardt disease affects around one in 6,500 people and is therefore a rare disease. Those affected increasingly lose the ability to see in the center of their field of vision, which makes it difficult to recognize faces and read. The symptoms usually begin before the age of 20, often in childhood. There is currently no effective treatment.

A research team led by Professor Bence György and Professor Botond Roska from the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and the University of Basel, has developed a therapy to correct the genetic cause of Stargardt disease.

The study, which they conducted in collaboration with scientists David Bryson and Giuseppe Ciaramella from the biotechnology enterprise Beam Therapeutics, was published in the journal Nature Medicine.

Correcting the most common mutation

The team employed a technique called “base editing,” which enables researchers to replace individual building blocks of the DNA code, known as nucleotide bases.

For their therapeutic approach, the researchers developed a molecular system targeting the nucleotide adenine at a specific site in the genome. This system is delivered into retinal cells using modified viral vectors. The goal is to correct the most common mutation associated with Stargardt disease.

“Our approach achieves remarkably high rates of gene correction,” said György. “We observed average editing rates of 75% in cone cells and 87% in retinal pigment epithelial cells. These rates far exceed what we believe is necessary to provide clinical benefit to patients.”

Tested in human tissue

The effectiveness of this technique was demonstrated in human tissue, including human retinas from organ donors. The researchers are confident that their treatment has a high likelihood of being translatable to patients.

First author Alissa Muller, a doctoral student at IOB, highlighted the precision and safety of the technique, “We conducted extensive off-target analyses and found no evidence of unintended edits in the retina or other parts of the body. This is critical for developing a safe and effective therapy.”

Applicable for other inherited retinal diseases

The researchers also emphasized that their base editing approach could potentially be adapted to treat other inherited retinal diseases caused by similar mutations. The results represent a significant advancement in ocular gene therapy. Next steps may include further safety studies and preparations for clinical trials.

If successful, this gene editing approach could provide hope to thousands of people affected by Stargardt disease and potentially other inherited retinal disorders.

More information:
Alissa Muller et al, High-efficiency base editing in the retina in primates and human tissues, Nature Medicine (2025). DOI: 10.1038/s41591-024-03422-8

Provided by
University of Basel


Citation:
Precision gene editing could prevent vision loss from Stargardt disease (2025, January 10)
retrieved 10 January 2025
from https://medicalxpress.com/news/2025-01-precision-gene-vision-loss-stargardt.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Precision gene editing could prevent vision loss from Stargardt disease
Among the rare diseases, Stargardt disease is one of the most common affecting the retina. Credit: IOB

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, which often leads to vision loss. Their study shows promising results using a precise technique for gene correction.

Stargardt disease affects around one in 6,500 people and is therefore a rare disease. Those affected increasingly lose the ability to see in the center of their field of vision, which makes it difficult to recognize faces and read. The symptoms usually begin before the age of 20, often in childhood. There is currently no effective treatment.

A research team led by Professor Bence György and Professor Botond Roska from the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and the University of Basel, has developed a therapy to correct the genetic cause of Stargardt disease.

The study, which they conducted in collaboration with scientists David Bryson and Giuseppe Ciaramella from the biotechnology enterprise Beam Therapeutics, was published in the journal Nature Medicine.

Correcting the most common mutation

The team employed a technique called “base editing,” which enables researchers to replace individual building blocks of the DNA code, known as nucleotide bases.

For their therapeutic approach, the researchers developed a molecular system targeting the nucleotide adenine at a specific site in the genome. This system is delivered into retinal cells using modified viral vectors. The goal is to correct the most common mutation associated with Stargardt disease.

“Our approach achieves remarkably high rates of gene correction,” said György. “We observed average editing rates of 75% in cone cells and 87% in retinal pigment epithelial cells. These rates far exceed what we believe is necessary to provide clinical benefit to patients.”

Tested in human tissue

The effectiveness of this technique was demonstrated in human tissue, including human retinas from organ donors. The researchers are confident that their treatment has a high likelihood of being translatable to patients.

First author Alissa Muller, a doctoral student at IOB, highlighted the precision and safety of the technique, “We conducted extensive off-target analyses and found no evidence of unintended edits in the retina or other parts of the body. This is critical for developing a safe and effective therapy.”

Applicable for other inherited retinal diseases

The researchers also emphasized that their base editing approach could potentially be adapted to treat other inherited retinal diseases caused by similar mutations. The results represent a significant advancement in ocular gene therapy. Next steps may include further safety studies and preparations for clinical trials.

If successful, this gene editing approach could provide hope to thousands of people affected by Stargardt disease and potentially other inherited retinal disorders.

More information:
Alissa Muller et al, High-efficiency base editing in the retina in primates and human tissues, Nature Medicine (2025). DOI: 10.1038/s41591-024-03422-8

Provided by
University of Basel


Citation:
Precision gene editing could prevent vision loss from Stargardt disease (2025, January 10)
retrieved 10 January 2025
from https://medicalxpress.com/news/2025-01-precision-gene-vision-loss-stargardt.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Judge will weigh holding Giuliani in contempt after $148 million defamation award

Next Post

Supply chain collaboration key to UK clean power ambition

Related Posts

baby

Brain connections at 3 months predict infant emotional development

June 3, 2025
4

Influencer Urges Parents to Give Kids Bleach to Treat Autism Despite Reports of Vomiting, Suffering Seizures: Report

June 3, 2025
6
Next Post
wind turbine base and personnel cabin

Supply chain collaboration key to UK clean power ambition

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0

China passenger trips up 3% during Dragon Boat holiday todayheadline

June 3, 2025
ET logo

Who is Alex Marquardt, and how a defamation case cost CNN nearly $5 million todayheadline

June 3, 2025
artist image of young star system

Water Discovered Around a Young, Sun-Like Star For First Time : ScienceAlert todayheadline

June 3, 2025
Ptolemaeus, Alphonsus, and Arzachel

The Sky Today on Tuesday, June 3: A trio of craters

June 3, 2025

Recent News

China passenger trips up 3% during Dragon Boat holiday todayheadline

June 3, 2025
0
ET logo

Who is Alex Marquardt, and how a defamation case cost CNN nearly $5 million todayheadline

June 3, 2025
3
artist image of young star system

Water Discovered Around a Young, Sun-Like Star For First Time : ScienceAlert todayheadline

June 3, 2025
1
Ptolemaeus, Alphonsus, and Arzachel

The Sky Today on Tuesday, June 3: A trio of craters

June 3, 2025
3

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

China passenger trips up 3% during Dragon Boat holiday todayheadline

June 3, 2025
ET logo

Who is Alex Marquardt, and how a defamation case cost CNN nearly $5 million todayheadline

June 3, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co